These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27377124)

  • 21. A Combination of Native LC-MS Approaches for the Comprehensive Characterization of the Antibody-Drug Conjugate Trastuzumab Deruxtecan.
    Deslignière E; Diemer H; Erb S; Coliat P; Pivot X; Detappe A; Hernandez-Alba O; Cianférani S
    Front Biosci (Landmark Ed); 2022 Oct; 27(10):290. PubMed ID: 36336868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of ADCs by Native Mass Spectrometry.
    Hernandez-Alba O; Ehkirch A; Beck A; Cianférani S
    Methods Mol Biol; 2020; 2078():197-211. PubMed ID: 31643058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug Loading and Distribution of ADCs After Reduction or IdeS Digestion and Reduction.
    Wagner-Rousset E; Colas O; François YN; Heinisch S; Guillarme D; Cianférani S; Beck A
    Methods Mol Biol; 2020; 2078():187-195. PubMed ID: 31643057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LC-MS/MS method for the simultaneous determination of Lys-MCC-DM1, MCC-DM1 and DM1 as potential intracellular catabolites of the antibody-drug conjugate trastuzumab emtansine (T-DM1).
    Liu Y; Zhou F; Sang H; Ye H; Chen Q; Yao L; Ni P; Wang G; Zhang J
    J Pharm Biomed Anal; 2017 Apr; 137():170-177. PubMed ID: 28131055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LC-HRMS quantitation of intact antibody drug conjugate trastuzumab emtansine from rat plasma.
    Jin W; Burton L; Moore I
    Bioanalysis; 2018 Jun; 10(11):851-862. PubMed ID: 29863890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural characterization of antibody drug conjugate by a combination of intact, middle-up and bottom-up techniques using sheathless capillary electrophoresis - Tandem mass spectrometry as nanoESI infusion platform and separation method.
    Said N; Gahoual R; Kuhn L; Beck A; François YN; Leize-Wagner E
    Anal Chim Acta; 2016 Apr; 918():50-9. PubMed ID: 27046210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Site-Specific Conjugation Quantitation of a Cysteine-Conjugated Antibody-Drug Conjugate Using Stable Isotope Labeling Peptide Mapping LC-MS/MS Analysis.
    Davis TK; Jennings ME
    Anal Chem; 2022 Feb; 94(6):2772-2778. PubMed ID: 35100801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of drug load variants in a thiol linked antibody-drug conjugate using multidimensional chromatography.
    Gilroy JJ; Eakin CM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():182-189. PubMed ID: 28622622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated On-tip Affinity Capture Coupled with Mass Spectrometry to Characterize Intact Antibody-Drug Conjugates from Blood.
    Li KS; Chu PY; Fourie-O'Donohue A; Srikumar N; Kozak KR; Liu Y; Tran JC
    J Am Soc Mass Spectrom; 2018 Jul; 29(7):1532-1537. PubMed ID: 29845559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Native-MS Analysis of Monoclonal Antibody Conjugates by Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
    Campuzano IDG; Netirojjanakul C; Nshanian M; Lippens JL; Kilgour DPA; Van Orden S; Loo JA
    Anal Chem; 2018 Jan; 90(1):745-751. PubMed ID: 29193956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.
    Qu M; An B; Shen S; Zhang M; Shen X; Duan X; Balthasar JP; Qu J
    Mass Spectrom Rev; 2017 Nov; 36(6):734-754. PubMed ID: 27097288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-to-antibody ratio (DAR) and drug load distribution by LC-ESI-MS.
    Basa L
    Methods Mol Biol; 2013; 1045():285-93. PubMed ID: 23913155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physicochemical stability of the antibody-drug conjugate Trastuzumab-DM1: changes due to modification and conjugation processes.
    Wakankar AA; Feeney MB; Rivera J; Chen Y; Kim M; Sharma VK; Wang YJ
    Bioconjug Chem; 2010 Sep; 21(9):1588-95. PubMed ID: 20698491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid Analysis of Reduced Antibody Drug Conjugate by Online LC-MS/MS with Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
    Larson EJ; Zhu Y; Wu Z; Chen B; Zhang Z; Zhou S; Han L; Zhang Q; Ge Y
    Anal Chem; 2020 Nov; 92(22):15096-15103. PubMed ID: 33108180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-Time Analysis on Drug-Antibody Ratio of Antibody-Drug Conjugates for Synthesis, Process Optimization, and Quality Control.
    Tang Y; Tang F; Yang Y; Zhao L; Zhou H; Dong J; Huang W
    Sci Rep; 2017 Aug; 7(1):7763. PubMed ID: 28798339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry.
    Xu K; Liu L; Saad OM; Baudys J; Williams L; Leipold D; Shen B; Raab H; Junutula JR; Kim A; Kaur S
    Anal Biochem; 2011 May; 412(1):56-66. PubMed ID: 21216214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical studies of a Pro-antibody-drug conjugate designed to selectively target EGFR-overexpressing tumors with improved therapeutic efficacy.
    Yang Y; Guo Q; Chen X; Zhang J; Guo H; Qian W; Hou S; Dai J; Li B; Guo Y; Wang H
    MAbs; 2016; 8(2):405-13. PubMed ID: 26760045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Affinity profiling of monoclonal antibody and antibody-drug-conjugate preparations by coupled liquid chromatography-surface plasmon resonance biosensing.
    Lakayan D; Haselberg R; Gahoual R; Somsen GW; Kool J
    Anal Bioanal Chem; 2018 Dec; 410(30):7837-7848. PubMed ID: 30328504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple heart-cutting and comprehensive two-dimensional liquid chromatography hyphenated to mass spectrometry for the characterization of the antibody-drug conjugate ado-trastuzumab emtansine.
    Sandra K; Vanhoenacker G; Vandenheede I; Steenbeke M; Joseph M; Sandra P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():119-130. PubMed ID: 27160547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Internal Fragments Enhance Middle-Down Mass Spectrometry Structural Characterization of Monoclonal Antibodies and Antibody-Drug Conjugates.
    Wei B; Lantz C; Ogorzalek Loo RR; Campuzano IDG; Loo JA
    Anal Chem; 2024 Feb; 96(6):2491-2499. PubMed ID: 38294207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.